These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 25403429)

  • 1. Cross-sex hormone therapy for gender dysphoria.
    Fabris B; Bernardi S; Trombetta C
    J Endocrinol Invest; 2015 Mar; 38(3):269-82. PubMed ID: 25403429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
    Smith KP; Madison CM; Milne NM
    Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria.
    Fisher AD; Castellini G; Bandini E; Casale H; Fanni E; Benni L; Ferruccio N; Meriggiola MC; Manieri C; Gualerzi A; Jannini E; Oppo A; Ricca V; Maggi M; Rellini AH
    J Sex Med; 2014 Mar; 11(3):709-19. PubMed ID: 24330520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals.
    Zubiaurre-Elorza L; Junque C; Gómez-Gil E; Guillamon A
    J Sex Med; 2014 May; 11(5):1248-61. PubMed ID: 24617977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.
    Mepham N; Bouman WP; Arcelus J; Hayter M; Wylie KR
    J Sex Med; 2014 Dec; 11(12):2995-3001. PubMed ID: 25213018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent development and psychosocial functioning after starting cross-sex hormones for gender dysphoria.
    Kaltiala R; Heino E; Työläjärvi M; Suomalainen L
    Nord J Psychiatry; 2020 Apr; 74(3):213-219. PubMed ID: 31762394
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
    Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adolescents with gender identity disorder: reconsideration of the age limits for endocrine treatment and surgery].
    Nakatsuka M
    Seishin Shinkeigaku Zasshi; 2012; 114(6):647-53. PubMed ID: 22844815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfeminine Hormone Therapy.
    Hamidi O; Davidge-Pitts CJ
    Endocrinol Metab Clin North Am; 2019 Jun; 48(2):341-355. PubMed ID: 31027544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D; T'Sjoen G; Ravn P; Andersen MS
    Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular Functions and Clinical Characterization of Patients with Gender Dysphoria (GD) Undergoing Sex Reassignment Surgery (SRS).
    Schneider F; Neuhaus N; Wistuba J; Zitzmann M; Heß J; Mahler D; van Ahlen H; Schlatt S; Kliesch S
    J Sex Med; 2015 Nov; 12(11):2190-200. PubMed ID: 26559385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Body Uneasiness, Eating Attitudes, and Psychopathology Before and After Cross-Sex Hormonal Treatment in Patients with Female-to-Male Gender Dysphoria.
    Turan Ş; Aksoy Poyraz C; Usta Sağlam NG; Demirel ÖF; Haliloğlu Ö; Kadıoğlu P; Duran A
    Arch Sex Behav; 2018 Nov; 47(8):2349-2361. PubMed ID: 29594702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ; Cheung AS
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross sex hormone treatment is linked with a reversal of cerebral patterns associated with gender dysphoria to the baseline of cisgender controls.
    Kilpatrick LA; Holmberg M; Manzouri A; Savic I
    Eur J Neurosci; 2019 Oct; 50(8):3269-3281. PubMed ID: 30991464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data.
    Fisher AD; Castellini G; Ristori J; Casale H; Cassioli E; Sensi C; Fanni E; Amato AM; Bettini E; Mosconi M; Dèttore D; Ricca V; Maggi M
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4260-4269. PubMed ID: 27700538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgender and Gender Nonconforming Youth.
    Forcier M; Olson J
    Adolesc Med State Art Rev; 2014 Aug; 25(2):377-97. PubMed ID: 27132320
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals.
    Bunck MC; Giltay EJ; Diamant M; Gooren LJ; Teerlink T
    Atherosclerosis; 2009 Sep; 206(1):245-50. PubMed ID: 19324362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transsexual Voice Questionnaire for Male-to-female Brazilian Transsexual People.
    Schwarz K; Fontanari AMV; Mueller A; Costa AB; Soll B; da Silva DC; Cielo CA; Kuhl G; Spritzer PM; Schneider MA; Dorfmann ME; Lobato MIR
    J Voice; 2017 Jan; 31(1):120.e15-120.e20. PubMed ID: 27146028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function.
    Schneider F; Kliesch S; Schlatt S; Neuhaus N
    Andrology; 2017 Sep; 5(5):873-880. PubMed ID: 28914501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.
    Moore E; Wisniewski A; Dobs A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3467-73. PubMed ID: 12915619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.